Welcome! If you have a coupon code, click here to apply it. Apply

AONC $0.00 (+0.00%) Quote details

stock

American Oncology Network Inc.

NASDAQ | AONC

6.49

USD

+0.00 (+0.00%)

AT CLOSE (AS OF Apr 25, 2025)

$190M

MARKET CAP

-

P/E Ratio

-0.89

EPS

$6.7

52 Week High

$1

52 Week Low

REAL ESTATE & CONSTRUCTION

Sector

No Analyst Rating
data available.

AONC Chart

1D
Area

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

AONC Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $118M
Total Revenue $1.8B
Cost Of Revenue $1.6B
Costof Goods And Services Sold $1.6B
Operating Income -$17M
Selling General And Administrative $134M
Research And Development -
Operating Expenses $135M
Investment Income Net -
Net Interest Income -$3.9M
Interest Income $3.2M
Interest Expense $7.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $127K
Income Before Tax -$7M
Income Tax Expense $2.5M
Interest And Debt Expense -
Net Income From Continuing Operations -$27M
Comprehensive Income Net Of Tax -
Ebit -$18M
Ebitda -$17M
Net Income -$4M

Revenue & Profitability

Earnings Performance

Actual: $undefined
Estimate: $undefined
Difference: $undefined
Period Qundefined
Q3 23Q4 23Q1 24Q2 24-$0.00-$0.00-$0.00-$0.00

AONC Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $470M
Total Current Assets $331M
Cash And Cash Equivalents At Carrying Value $63M
Cash And Short Term Investments $63M
Inventory $61M
Current Net Receivables -
Total Non Current Assets $139M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $2.5M
Intangible Assets Excluding Goodwill $2.5M
Goodwill $11M
Investments -
Long Term Investments $0
Short Term Investments $9.8M
Other Current Assets $8.5M
Other Non Current Assets -
Total Liabilities $362M
Total Current Liabilities $217M
Current Accounts Payable -
Deferred Revenue -
Current Debt -
Short Term Debt $11M
Total Non Current Liabilities $145M
Capital Lease Obligations $57M
Long Term Debt $87M
Current Long Term Debt $3.7M
Long Term Debt Noncurrent -
Short Long Term Debt Total $59M
Other Current Liabilities $34M
Other Non Current Liabilities $10M
Total Shareholder Equity -$46M
Treasury Stock -
Retained Earnings -$102M
Common Stock $4K
Common Stock Shares Outstanding $14M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$4.9M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $19M
Capital Expenditures $21M
Change In Receivables -
Change In Inventory -$14M
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $42M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$368K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$27M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $118M
Total Revenue $1.8B
Cost Of Revenue $1.6B
Costof Goods And Services Sold $1.6B
Operating Income -$17M
Selling General And Administrative $134M
Research And Development -
Operating Expenses $135M
Investment Income Net -
Net Interest Income -$3.9M
Interest Income $3.2M
Interest Expense $7.1M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $127K
Income Before Tax -$7M
Income Tax Expense $2.5M
Interest And Debt Expense -
Net Income From Continuing Operations -$27M
Comprehensive Income Net Of Tax -
Ebit -$18M
Ebitda -$17M
Net Income -$4M

AONC News

News Sentiment

The news sentiment chart shows the sentiment of news articles related to the symbol.

American Oncology Network Inc. Top Stories

MidAmerica Cancer Care Opens New Medical Oncology Clinic in Kansas City, Kansas

MidAmerica Cancer Care Opens New Medical Oncology Clinic in Kansas City, Kansas - 2 April 2025

MidAmerica Cancer Care Joins American Oncology Network

MidAmerica Cancer Care Joins American Oncology Network - 22 January 2025

American Oncology Network Appoints Charlie Goddard as General Counsel

American Oncology Network Appoints Charlie Goddard as General Counsel - 15 January 2025

American Oncology Network's Specialty Pharmacy Achieves ACHC Reaccreditation - American Oncology Network  ( OTC:AONC )

American Oncology Network's Specialty Pharmacy Achieves ACHC Reaccreditation - American Oncology Network ( OTC:AONC ) - 19 December 2024

American Oncology Network  ( AON )  and Vantage Health Technologies Partner to Improve Cancer Patient Outcomes with AI-enabled Value-Based Care Platform - American Oncology Network  ( OTC:AONC )

American Oncology Network ( AON ) and Vantage Health Technologies Partner to Improve Cancer Patient Outcomes with AI-enabled Value-Based Care Platform - American Oncology Network ( OTC:AONC ) - 29 October 2024

American Oncology Network Announces the Commencement of OTCQX Trading

American Oncology Network Announces the Commencement of OTCQX Trading - 10 June 2024

OTC Markets Group Welcomes American Oncology Network, Inc. to OTCQX

OTC Markets Group Welcomes American Oncology Network, Inc. to OTCQX - 10 June 2024

Gold Moves Lower; Macy's Boosts 2024 Forecast - Biodexa Pharmaceuticals  ( NASDAQ:BDRX ) , American Oncology Network  ( NASDAQ:AONC )

Gold Moves Lower; Macy's Boosts 2024 Forecast - Biodexa Pharmaceuticals ( NASDAQ:BDRX ) , American Oncology Network ( NASDAQ:AONC ) - 21 May 2024

Crude Oil Moves Lower; Lowe's Earnings Top Views - Lowe's Companies  ( NYSE:LOW )

Crude Oil Moves Lower; Lowe's Earnings Top Views - Lowe's Companies ( NYSE:LOW ) - 21 May 2024

American Oncology Network Announces Voluntary Delisting From Nasdaq

American Oncology Network Announces Voluntary Delisting From Nasdaq - 21 May 2024

American Oncology Network Appoints New Board Member - American Oncology Network  ( NASDAQ:AONC )

American Oncology Network Appoints New Board Member - American Oncology Network ( NASDAQ:AONC ) - 16 May 2024

American Oncology Network, Inc. Announces First Quarter 2024 Financial Results

American Oncology Network, Inc. Announces First Quarter 2024 Financial Results - 15 May 2024

Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update

Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update - 14 May 2024

American Oncology Network Announces CFO Transition - American Oncology Network  ( NASDAQ:AONC )

American Oncology Network Announces CFO Transition - American Oncology Network ( NASDAQ:AONC ) - 3 May 2024

American Oncology Network Announces CFO Transition

American Oncology Network Announces CFO Transition - 3 May 2024

American Oncology Network, Inc.  ( "AON" )  Announces Fourth Quarter and Full Year 2023 Financial Results

American Oncology Network, Inc. ( "AON" ) Announces Fourth Quarter and Full Year 2023 Financial Results - 28 March 2024

Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update

Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update - 27 March 2024

Thyme Care Unveils "Thyme Care Oncology Partners," a Provider-Powered Value-Based Care Model in Partnership with More than 400 Oncologists Nationwide

Thyme Care Unveils "Thyme Care Oncology Partners," a Provider-Powered Value-Based Care Model in Partnership with More than 400 Oncologists Nationwide - 13 March 2024

Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting

Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting - 11 January 2024

American Oncology Network, Inc. Announces Third Quarter 2023 Financial Results - American Oncology Network  ( NASDAQ:AONC )

American Oncology Network, Inc. Announces Third Quarter 2023 Financial Results - American Oncology Network ( NASDAQ:AONC ) - 14 November 2023

American Oncology Network, Inc. Announces Third Quarter 2023 Financial Results

American Oncology Network, Inc. Announces Third Quarter 2023 Financial Results - 14 November 2023

Stocks That Hit 52-Week Lows On Thursday - PRA Group  ( NASDAQ:PRAA ) , Perimeter Solutions  ( NYSE:PRM )

Stocks That Hit 52-Week Lows On Thursday - PRA Group ( NASDAQ:PRAA ) , Perimeter Solutions ( NYSE:PRM ) - 5 October 2023

Stocks That Hit 52-Week Lows On Wednesday - Bristol-Myers Squibb Company Common Stock  ( NYSE:BMY ) , SenesTech, Inc. - Common Stock  ( NASDAQ:SNES )

Stocks That Hit 52-Week Lows On Wednesday - Bristol-Myers Squibb Company Common Stock ( NYSE:BMY ) , SenesTech, Inc. - Common Stock ( NASDAQ:SNES ) - 4 October 2023

AONC Profile

American Oncology Network Inc. Profile

Sector: REAL ESTATE & CONSTRUCTION

Industry: BLANK CHECKS

American Oncology Network, Inc., provides oncology services in the United States. The company is headquartered in Fort Myers, Florida.

GNLN
-17.33%
$0.0124
AGMH
24.62%
$0.0486
OMEX
77.21%
$1.51
RTC
75.42%
$0.3254
NVDA
4.30%
$111.01
DMN
-2.78%
$0.0035
WW
168.02%
$0.3956
TSLA
9.80%
$284.95
INTC
-6.70%
$20.05
PLTR
4.64%
$112.78
ALTM
0.00%
$5.84
F
-0.20%
$10.04
STSS
-5.61%
$0.0202
SOFI
4.63%
$12.88
LCID
2.04%
$2.5
AAL
1.46%
$9.75
PLUG
-4.36%
$0.8116
AZUL
-26.54%
$0.8301
BTG
-2.22%
$3.08
GOOGL
1.68%
$161.96
LYT
-16.78%
$0.0982
ABEV
0.41%
$2.47
LGMK
-6.45%
$0.0087
AVTR
-16.58%
$12.93
AZTR
3.86%
$0.3178
PONY
-7.40%
$7.01
NIO
-3.59%
$4.03
APLD
3.52%
$4.7
WULF
-1.32%
$3
QBTS
2.45%
$7.53
AAPL
0.44%
$209.28
SMCI
1.84%
$36.47
SXTC
44.94%
$2.29
GRAB
2.14%
$4.78
DNN
-2.11%
$1.39
IQ
0.52%
$1.92
T
-2.62%
$26.81
AGNC
1.49%
$8.85
RGTI
0.75%
$9.37
AMZN
1.31%
$188.99
PFE
0.61%
$22.92
GOOG
1.47%
$163.85
HOOD
2.70%
$49.45
OLB
27.21%
$1.8
VALE
-2.56%
$9.5
SNAP
2.52%
$8.54
BAC
0.28%
$39.69
MARA
2.07%
$14.3
TLRY
-1.06%
$0.4871
JYD
16.58%
$0.2623
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
KITT
-2.68%
$1.09
AMD
2.30%
$96.645
MRK
3.63%
$82.74
RIOT
-0.26%
$7.77
IONQ
1.80%
$28.9
CEP
27.02%
$31.5
CMG
4.52%
$51.78
BTE
0.61%
$1.65
SOUN
1.49%
$9.52
CLSK
1.69%
$9.01
BBD
0.00%
$2.38
AMCR
-1.24%
$9.54
RIG
1.75%
$2.33
SMMT
-36.06%
$23.465
WBD
1.06%
$8.59
RIVN
4.38%
$12.62
ERIC
-0.49%
$8.19
SLB
-1.17%
$34.52
VZ
-2.10%
$41.91
KVUE
1.14%
$23.01
BTOG
3.99%
$0.1537
TMC
-17.34%
$3.05
VRN
0.33%
$6.13
NGD
-2.02%
$3.39
ITUB
0.00%
$6.14
AVGO
2.21%
$192.31
NOK
2.67%
$4.99
OCEA
-13.47%
$0.0085
ACHR
0.35%
$8.59
UBER
-0.45%
$77.75
JBLU
-1.52%
$3.88
MU
3.05%
$79.78
FNA
0.00%
$13.09
MSTR
5.24%
$368.71
CGC
-5.37%
$1.41
MSFT
1.17%
$391.85
CX
4.04%
$5.92
AG
-0.80%
$6.19
HBAN
-1.03%
$14.4
HL
-0.51%
$5.85
WFC
0.24%
$69.73
AREB
-1.79%
$3.85
NKE
-1.47%
$57.62
META
2.65%
$547.27
HTZ
-4.05%
$8.3
CSCO
0.75%
$56.71
KO
-0.84%
$71.91
BMY
-1.62%
$47.9
GNLN
-17.33%
$0.0124
AGMH
24.62%
$0.0486
OMEX
77.21%
$1.51
RTC
75.42%
$0.3254
NVDA
4.30%
$111.01
DMN
-2.78%
$0.0035
WW
168.02%
$0.3956
TSLA
9.80%
$284.95
INTC
-6.70%
$20.05
PLTR
4.64%
$112.78
ALTM
0.00%
$5.84
F
-0.20%
$10.04
STSS
-5.61%
$0.0202
SOFI
4.63%
$12.88
LCID
2.04%
$2.5
AAL
1.46%
$9.75
PLUG
-4.36%
$0.8116
AZUL
-26.54%
$0.8301
BTG
-2.22%
$3.08
GOOGL
1.68%
$161.96
LYT
-16.78%
$0.0982
ABEV
0.41%
$2.47
LGMK
-6.45%
$0.0087
AVTR
-16.58%
$12.93
AZTR
3.86%
$0.3178
PONY
-7.40%
$7.01
NIO
-3.59%
$4.03
APLD
3.52%
$4.7
WULF
-1.32%
$3
QBTS
2.45%
$7.53
AAPL
0.44%
$209.28
SMCI
1.84%
$36.47
SXTC
44.94%
$2.29
GRAB
2.14%
$4.78
DNN
-2.11%
$1.39
IQ
0.52%
$1.92
T
-2.62%
$26.81
AGNC
1.49%
$8.85
RGTI
0.75%
$9.37
AMZN
1.31%
$188.99
PFE
0.61%
$22.92
GOOG
1.47%
$163.85
HOOD
2.70%
$49.45
OLB
27.21%
$1.8
VALE
-2.56%
$9.5
SNAP
2.52%
$8.54
BAC
0.28%
$39.69
MARA
2.07%
$14.3
TLRY
-1.06%
$0.4871
JYD
16.58%
$0.2623
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
KITT
-2.68%
$1.09
AMD
2.30%
$96.645
MRK
3.63%
$82.74
RIOT
-0.26%
$7.77
IONQ
1.80%
$28.9
CEP
27.02%
$31.5
CMG
4.52%
$51.78
BTE
0.61%
$1.65
SOUN
1.49%
$9.52
CLSK
1.69%
$9.01
BBD
0.00%
$2.38
AMCR
-1.24%
$9.54
RIG
1.75%
$2.33
SMMT
-36.06%
$23.465
WBD
1.06%
$8.59
RIVN
4.38%
$12.62
ERIC
-0.49%
$8.19
SLB
-1.17%
$34.52
VZ
-2.10%
$41.91
KVUE
1.14%
$23.01
BTOG
3.99%
$0.1537
TMC
-17.34%
$3.05
VRN
0.33%
$6.13
NGD
-2.02%
$3.39
ITUB
0.00%
$6.14
AVGO
2.21%
$192.31
NOK
2.67%
$4.99
OCEA
-13.47%
$0.0085
ACHR
0.35%
$8.59
UBER
-0.45%
$77.75
JBLU
-1.52%
$3.88
MU
3.05%
$79.78
FNA
0.00%
$13.09
MSTR
5.24%
$368.71
CGC
-5.37%
$1.41
MSFT
1.17%
$391.85
CX
4.04%
$5.92
AG
-0.80%
$6.19
HBAN
-1.03%
$14.4
HL
-0.51%
$5.85
WFC
0.24%
$69.73
AREB
-1.79%
$3.85
NKE
-1.47%
$57.62
META
2.65%
$547.27
HTZ
-4.05%
$8.3
CSCO
0.75%
$56.71
KO
-0.84%
$71.91
BMY
-1.62%
$47.9
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.